NaveenPremnathMD

PubMed

• Possible role of IL-23 inhibitor in autoimmune hemolytic anemia.
  Naveen Premnath, Urvashi Pandey, Mohak Pandey, K Venuprasad> ;European Journal of Haematology. 2023 Sep 1
• 1 citations
  Paradigm Shift in the Management of Acute Myeloid Leukemia-Approved Options in 2023.
  Naveen Premnath, Yazan F Madanat> ;Cancers. 2023 May 31
• 1 citations
  Novel Investigational Agents and Pathways That May Influence the Future Management of Acute Myeloid Leukemia.
  Naveen Premnath, Yazan F Madanat> ;Cancers. 2023 May 29
• Post-transplant cyclophosphamide and early mixed donor Chimerism in myeloid malignancies; a single-center experience.
  Fieke W Hoff, Stephen S Chung, Prapti A Patel, Naveen Premnath, Jude Khatib, Mirjana Tadic-Ovcina, Abeer AhmedRabie, Debra Helton, Selamawit Yohannes, Jaime Shahan, He...> ;Transplant Immunology. 2023 Apr 1
• 3 citations
  Clinical and molecular characteristics associated with Vitamin C deficiency in myeloid malignancies; real world data from a prospective cohort.
  Naveen Premnath, Stephen S Chung, Olga K Weinberg, Ruth Ikpefan, Mohak Pandey, Gurbakhash Kaur, Praveen Ramakrishnan Geethakumari, Aimaz Afrough, Farrukh T Awan, Larry...> ;Leukemia Research. 2023 Feb 1
• 5 citations
  Analysis of the impact of COVID-19 pandemic on house-staff in the USA: addressing the ripple effects
  Udhayvir Singh Grewal, Naveen Premnath, Nakul Bhardwaj, Aakash Sheth, Subhash Garikipati, Shiva Jashwanth Gaddam, Parth R. Shah, Elizabeth Paulk> ;Journal of Community Hospital Internal Medicine Perspectives. 2021 Jun 21
• 6 citations
  Projected 30- day out-of-pocket costs and total spending on pancreatic enzyme replacement therapy under Medicare Part D.
  Arjun Gupta, Naveen Premnath, Ramy Sedhom, Muhammad Shaalan Beg, Rohan Khera, Daniel A. Laheru, Stacie B. Dusetzina> ;Pancreatology. 2021 May 11
• 5 citations
  Use of Peripheral μ-Opioid Receptor Antagonists for Treating Opioid-Induced Constipation among US Medicare Beneficiaries from 2014 to 2018.
  Naveen Premnath, Andrew Sumarsono, Ramy Sedhom, David H. Johnson, Ishwaria Mohan Subbiah, Sydney M. Dy, Arjun Gupta> ;Journal of Palliative Medicine. 2021 Apr 19
• 4 citations
  BReast CAncer ( BRCA ) gene mutations as an emerging biomarker for the treatment of gastrointestinal malignancies
  Naveen Premnath, Eileen M O'Reilly> ;Chinese Clinical Oncology. 2020 Aug 10
• 4 citations
  Assessment of Racial Differences in Rates of Autopsy in the US, 2008-2017
  Arjun Gupta, Naveen Premnath, Pei-Lun Kuo, Ramy Sedhom, Otis W. Brawley, Fumiko Chino> ;JAMA Internal Medicine. 2020 Aug 1
• 3 citations
  Potential Cost Savings With Low-Dose Abiraterone in the United States.
  Naveen Premnath, Ramy Sedhom, Arjun Gupta> ;JCO Global Oncology. 2020 May 21
• 8 citations
  Park the Parking
  Naveen Premnath, Udhayvir Singh Grewal, Arjun Gupta> ;JCO Oncology Practice. 2020 Apr 3
• 4 citations
  Dissemination of Information on Neutropenic Diet by Top US Cancer Centers: In-line with the Evidence?
  Timothy J. Brown, Dhruvika Mukhija, Naveen Premnath, Anand Venkatraman, Sajan Jiv Singh Nagpal, Arjun Gupta> ;Nutrition and Cancer. 2019 May 2
• Unusual cause of neck pain
  Pakhi Goel, Naveen Premnath, Mugdha Agrawal, Arjun Gupta> ;BMJ Case Reports. 2018 Mar 5
• 4 citations
  Trends in Outcomes of Patients With Metastatic Cancer Undergoing Intubation and Mechanical Ventilation: Results of the National Hospital Discharge Survey.
  Arjun Gupta, Avash Das, Raseen Tariq, Nizar Bhulani, Naveen Premnath, Dipesh Solanky, Ryan D. Frank, David H. Johnson, Sahil Khanna, Muhammad Shaalan Beg> ;Journal of the National Comprehensive Cancer Network. 2018 Mar 1
• Join now to see all

Journal Articles

• BReast CAncer (BRCA) Gene Mutations as an Emerging Biomarker for the Treatment of Gastrointestinal Malignancies  
  Naveen Premnath, MD, Annals of Palliative Medicine
• Assessment of Racial Differences in Rates of Autopsy in the US, 2008-2017  
  Naveen Premnath, MD, JAMA Internal Medicine

Abstracts/Posters

• Burden and etiologies of 30-day readmission after bone marrow transplant: Insights from National Readmission Database.
  Naveen Premnath, Karan Sud, Sathish Kumar Pondaiah, Arjun Gupta, Journal of Clinical Oncology, 5/20/2019
• Analysis of Etiologies At 30 Day Re-Admissions Among Elderly and Young Adults
  SK Pondaiah, K Sud, S Zajac, S Shah, LM-Y Chen, N Premnath, R Ernest Jean, American Thoracic Society 2019, 5/1/2019
• Impact of Discharge Disposition on 30-day Readmissions Among Patients Admitted with Septic Shock
  Karan Sud, Sathish Pondaiah, Naveen Premnath, Christian Olivo-Freites, Raymonde Jean, Critical Care Medicine, 1/1/2019
• Septic Shock: Analysis of Etiologies at 30-day Readmissions
  Sathish Pondaiah, Karan Sud, Naveen Premnath, Laura Chen, Ermias Jirru, Raymonde Jean, Critical Care Medicine, 1/1/2019
• SPEAR: Study of Patients with Para-Pneumonic Pleural Effusion who are Re-Admitted within 30 days
  Sathish Pondaiah, Karan Sud, Naveen Premnath, Karishma Bhatia, Adil Shujaat, Chest, 10/1/2018
• Dissemination of information on neutropenic diet (ND) by top U.S. cancer centers: In line with evidence?
  Dhruvika Mukhija, Naveen Premnath, Arjun Gupta, Anand Venkatraman, Sajan Jiv Singh Nagpal, Journal of Clinical Oncology, 5/20/2018
• RETROSPECTIVE REVIEW OF EFFICACY AND DOSE INTENSITY OF SECONDLINE(SL) NAB-PACLITAXEL PLUS GEMCITABINE (NABG) FOR PATIENTS WITHMETASTATIC PANCREATIC ADENOCARCINOMA (MPA...
  Shinoj Pattali, Jayakumar Sreenivasan, Naveen Premnath, Shannon Schmidt, Paul S Ritch, James P Thomas, Beth Erickson, Kathleen K Christians, SUsan Tsai, Douglas B Evan..., 50th annual meeting of Pancreas club, https://www.pancreasclub.com/wp-content/uploads/2017/10/PancreasClub_2016finalprogram.pdf, 5/20/2016
• Join now to see all

Lectures

• Burden and etiologies of 30-day readmission after bone marrow transplant: Insights from National Readmission Database. 
  2019 ASCO Annual Meeting - 6/1/2019